Skip to main content

ROYAL BANK OF CANADA

Bank

Position in PTGX — Protagonist Therapeutics, Inc

CIK 1000275 TORONTO, A6

Position in PTGX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$425,718
+$257,185 QoQ
Shares Held
3,473
+117.2% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#226
of 343 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PTGX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,116,200,383 across 427 Biotechnology names. PTGX ranks #80 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PTGX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $425,718 3,473
2026-03-31 $168,533 1,599
2025-12-31 $278,001 3,183
2025-09-30 $4,649,832 69,996
2025-06-30 $4,130,544 74,734
2025-03-31 $481,857 9,964
2024-12-31 $294,518 7,630
2024-09-30 $610,335 13,563
2024-06-30 $354,191 10,222
2024-03-31 $164,292 5,679
2023-12-31 $400,242 17,455
2023-09-30 $134,424 8,059
2023-06-30 $116,473 4,217
2023-03-31 $60,582 2,634
2022-12-31 $60,472 5,543
2022-09-30 $6,836 811
2022-06-30 $4,033 510
2022-03-31 $71,040 3,000
2021-12-31 $344,290 10,067
2021-09-30 $84,789 4,785
2021-06-30 $149,450 3,330
2021-03-31 $86,091 3,324
2020-12-31 $23,990 1,190
2020-09-30 $9,775 500
2020-06-30 $8,830 500
2020-03-31 $367 52